US Patent 7741297 Immunostimulatory, covalently lipidated oligonucleotides
Patent 7741297 was granted and assigned to Oncothyreon on June, 2010 by the United States Patent and Trademark Office.
All edits
Edits on 17 Apr, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 31 Oct, 2023
Golden AI
Edits made to:
Article (+302 characters)
Article
Patent abstract
Covalently lipidated oligonucleotides comprising the CpG dinucleotide unit, or an analogue thereof, may be used as immunostimulatory agents to protect against a disease caused by a cancer cell or a pathogen, either alone or in conjunction with immunogens and/or non-immunological agents.
Edits on 18 Sep, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Damayanthi Yalamati0
Myung-Gi Baek0
Rao Koganty0
Zi-Hua Jiang0
Edits on 28 Jun, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 26 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07741297 Immunostimulatory, covalently lipidated oligonucleotides US Patent 7741297 Immunostimulatory, covalently lipidated oligonucleotides
Infobox
Patent Number
07741297
Patent Number
7741297
Edits on 3 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 4 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07741297 Immunostimulatory, covalently lipidated oligonucleotides
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07741297
Date of patent
June 22, 2010
Patent application number
10502085
Date Filed
February 4, 2003
Patent primary examiner
Find more entities like US Patent 7741297 Immunostimulatory, covalently lipidated oligonucleotides
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
